Shareholder alert: the m&a class action firm announces the investigation of amryt pharma plc - amyt

New york , jan. 9, 2023 /prnewswire/ -- juan monteverde , founder and managing partner of the class action firm monteverde & associates pc (the "m&a class action firm"), a national securities firm rated top 50 in the 2018-2021 iss securities class action services report and headquartered at the empire state building in new york city, is investigating amryt pharma plc (nasdaq: amyt), relating to its proposed sale to chiesi farmaceutici spa. under the terms of the agreement, amyt shareholders are expected to receive $14.50 plus one contingent value right of up to $2.50 per american depositary share they own.
AMYT Ratings Summary
AMYT Quant Ranking